Discover 3 Asian Growth Stocks With Strong Insider Ownership
In the midst of easing trade tensions and cautious optimism in global markets, Asian economies are navigating a complex landscape shaped by external shocks and internal policy adjustments. As investors seek opportunities amid these shifting dynamics, companies with strong insider ownership often stand out for their alignment of interests between management and shareholders, potentially offering resilience in uncertain times.
Name
Insider Ownership
Earnings Growth
AcrelLtd (SZSE:300286)
34.2%
34.9%
WinWay Technology (TWSE:6515)
22.1%
21.4%
Seojin SystemLtd (KOSDAQ:A178320)
32.1%
39.3%
Laopu Gold (SEHK:6181)
36.4%
40.2%
Global Tax Free (KOSDAQ:A204620)
20.8%
35.1%
Oscotec (KOSDAQ:A039200)
21.1%
85.9%
Zhejiang Leapmotor Technology (SEHK:9863)
15.2%
61.9%
Suzhou Sunmun Technology (SZSE:300522)
35.4%
77.7%
Fulin Precision (SZSE:300432)
13.6%
74.7%
Vuno (KOSDAQ:A338220)
15.6%
148.2%
Click here to see the full list of 633 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: NCSOFT Corporation develops and publishes online games worldwide, with a market cap of ₩2.86 trillion.
Operations: The company's revenue is primarily derived from online games and game services, totaling ₩1.58 trillion.
Insider Ownership: 13.9%
Earnings Growth Forecast: 24.9% p.a.
NCSOFT's insider ownership aligns with its growth potential, although recent financial results show challenges. The company reported a net loss in Q4 2024 and decreased annual sales and income compared to the previous year. Despite these setbacks, earnings are forecast to grow significantly at 24.86% annually over the next three years, outpacing market averages. However, profit margins have declined and return on equity is expected to remain low at 6.6%.
Click to explore a detailed breakdown of our findings in NCSOFT's earnings growth report.
Our valuation report here indicates NCSOFT may be undervalued.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lakala Payment Co., Ltd. offers third-party and cross-border payment services in China with a market cap of CN¥17.82 billion.
Operations: Lakala Payment Co., Ltd. generates revenue through its third-party and cross-border payment services in China.
Insider Ownership: 12.8%
Earnings Growth Forecast: 31.9% p.a.
Lakala Payment's high insider ownership aligns with its growth trajectory, though recent financials reveal challenges. Q1 2025 results showed a decline in revenue to CNY 1.3 billion and net income to CNY 100.64 million compared to the previous year. Despite this, earnings are forecasted to grow significantly at 31.9% annually over the next three years, outpacing market averages, though profit margins have decreased and revenue growth lags behind market expectations.
Click here to discover the nuances of Lakala Payment with our detailed analytical future growth report.
The analysis detailed in our Lakala Payment valuation report hints at an inflated share price compared to its estimated value.
Simply Wall St Growth Rating: ★★★★★★
Overview: Grand Process Technology Corporation is a Taiwanese company involved in the manufacturing and sale of semiconductor equipment, with a market capitalization of NT$27.61 billion.
Operations: The company's revenue is primarily derived from its Equipment Manufacturing Segment at NT$2.09 billion, followed by the Chemical Raw Materials Manufacturing Department at NT$1.19 billion, the Equipment Sales Agent Department at NT$823.06 million, and the Software Sales Department at NT$61.84 million.
Insider Ownership: 12.5%
Earnings Growth Forecast: 26.9% p.a.
Grand Process Technology's strong insider ownership supports its growth potential, with recent earnings showing sales of TWD 4.07 billion and net income of TWD 845.45 million for 2024, both increasing from the previous year. Despite a volatile share price and an unstable dividend track record, revenue is forecast to grow at 26.8% annually, surpassing market expectations. Earnings are also expected to rise significantly at 26.9% per year, indicating robust future prospects despite current volatility.
Get an in-depth perspective on Grand Process Technology's performance by reading our analyst estimates report here.
Our valuation report here indicates Grand Process Technology may be overvalued.
Unlock our comprehensive list of 633 Fast Growing Asian Companies With High Insider Ownership by clicking here.
Seeking Other Investments? Rare earth metals are the new gold rush. Find out which 23 stocks are leading the charge.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include KOSE:A036570 SZSE:300773 and TPEX:3131.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
European markets edge higher as investors eye ECB interest rate decision
Markets are widely expecting the European Central Bank (ECB) to cut interest rates again at its monetary policy meeting later today. "At its most recent meeting in April, the ECB reduced its key interest rates by 25 basis points, bringing the deposit facility rate to 2.25%. Markets are now pricing in another cut in June, though expectations for further easing beyond that remain uncertain. A potential pause in July is gaining traction, as the ECB evaluates incoming economic data and inflation dynamics," market analysts at said. The latest decision will come as inflation in the euro area cooled more than expected in May, bolstering expectations that the ECB will announce another interest rate cut. Annual consumer price growth slowed to 1.9% in May, down from 2.2% in April, according to a flash estimate from Eurostat this week. The figure came in below economists' forecast of 2%, and marks the first time inflation has dipped below the ECB's 2% target since September 2024. The decline in headline inflation suggests that business uncertainty, partly driven by renewed global trade tensions and soft consumer demand, is weighing on pricing power across sectors. Core inflation, which strips out volatile food and energy prices, also showed signs of easing. It slowed to 2.4% in May, from 2.7% in April, falling below expectations of 2.5%. On a monthly basis, core prices rose by just 0.1%. Related Eurozone inflation falls below ECB 2% target in May: Rate cut in sight Meanwhile, Asian shares were mixed on Thursday, as Wall Street's big recent rally lost some momentum following a pair of potentially discouraging reports on the American economy. US futures edged lower and oil prices declined. Japan's benchmark Nikkei 225 shed 0.2% to 37,658.46, while Australia's S&P/ASX 200 declined nearly 0.1% to 8,535.10. In South Korea, the Kospi jumped 2.1% to 2,829.48 after the country's new president and leading liberal politician Lee Jae-myung began his term, vowing to restart talks with North Korea and beef up a trilateral partnership with the US and Japan. Hong Kong's Hang Seng gained 0.9% to 23,856.54, while the Shanghai Composite was little changed, inching down less than 0.1% to 3,374.30. On Wednesday, the S&P 500 finished the day virtually unchanged at 5,970.81 and remained 2.8% below its all-time high. The Dow Jones Industrial Average fell 0.2% to 42,427.74, and the tech-heavy Nasdaq composite added 0.3% to 19,460.49. The action was stronger in the bond market, where Treasury yields tumbled following weaker-than-expected economic updates. In other dealings early Thursday morning, benchmark US crude fell 8 cents to $62.77 a barrel. Brent crude, the international standard, edged up 1 cent to $64.87 a barrel. The US dollar rose to 142.87 Japanese yen from 142.78 yen. The euro cost $1.1413, little changed from $1.1418.
an hour ago
Asian shares trade mixed after Wall Street's rally stalls on U.S. economic data
TOKYO -- Asian shares were mixed on Thursday, as Wall Street's big recent rally lost some momentum following a pair of potentially discouraging reports on the American economy. U.S. futures edged lower and oil prices declined. Japan's benchmark Nikkei 225 shed 0.2% to 37,658.46, while Australia's S&P/ASX 200 declined nearly 0.1% to 8,535.10. In South Korea, the Kospi jumped 2.1% to 2,829.48 after the country's new president and leading liberal politician Lee Jae-myung began his term, vowing to restart talks with North Korea and beef up a trilateral partnership with the U.S. and Japan. Hong Kong's Hang Seng gained 0.9% to 23,856.54, while the Shanghai Composite was little changed, inching down less than 0.1% to 3,374.30. On Wednesday, the S&P 500 finished the day virtually unchanged at 5,970.81 and remained 2.8% below its all-time high. The Dow Jones Industrial Average fell 0.2% to 42,427.74, and the Nasdaq composite added 0.3% to 19,460.49. The action was stronger in the bond market, where Treasury yields tumbled following the weaker-than-expected economic updates. One said that activity contracted for U.S. retailers, finance companies and other businesses in the services industries last month, when economists were expecting to see growth. Businesses told the Institute for Supply Management in its survey that all the uncertainty created by tariffs is making it difficult for them to forecast and plan. A second report from ADP suggested U.S. employers outside of the government hired far fewer workers last month than economists expected. That could bode ill for Friday's more comprehensive jobs report coming from the U.S. Labor Department, which is one of Wall Street's most anticipated data releases each month. So far, the U.S. job market has remained remarkably resilient despite years of high inflation and now the threat of President Donald Trump's high tariffs. But weakness there could undermine the rest of the economy. Following the reports, traders built up bets that the Federal Reserve will need to cut interest rates later this year in order to prop up the economy, which in turn caused the fall for Treasury yields. The weaker-than-expected ADP report also led Trump to urge Fed Chair Jerome Powell to deliver cuts to rates more quickly. ''Too Late' Powell must now LOWER THE RATE,' Trump said on his Truth Social platform. 'He is unbelievable!!!' The Fed has yet to cut interest rates this year after slashing them through the end of 2024. Part of the reason for the pause is that the Fed wants to see how much Trump's tariffs will hurt the economy and raise inflation. While lower interest rates could boost the economy, they could also give inflation more fuel. Longer-term Treasury yields have also been rising in recent weeks because of reasons outside the Fed's control. Investors have been demanding the U.S. government pay more in interest to borrow because of worries about whether it's set to add trillions of dollars to its debt through tax cuts under discussion on Capitol Hill. Investors are hoping for deals that will lower Trump's tariffs. But nothing is assured. The European Union's top trade negotiator, Maroš Šefčovič, met Wednesday with his American counterpart, U.S. Trade Representative Jamieson Greer, on the sidelines of a meeting of the Organisation for Economic Cooperation and Development. In the bond market, the yield on the 10-year Treasury fell to 4.35% from 4.46% late Tuesday. The two-year Treasury yield, which more closely tracks traders' expectations for what the Fed will do with overnight interest rates, eased to 3.86% from 3.96%. In other dealings early Thursday, benchmark U.S. crude fell 8 cents to $62.77 a barrel. Brent crude, the international standard, edged up 1 cent to $64.87 a barrel. The U.S. dollar rose to 142.87 Japanese yen from 142.78 yen. The euro cost $1.1413, little changed from $1.1418. AP Business Writer Stan Choe contributed.
Yahoo
2 hours ago
- Yahoo
HighTide Therapeutics And 2 Other Asian Penny Stocks To Watch Closely
Amidst a backdrop of fluctuating global trade policies and easing inflation, Asian markets have been navigating a complex economic landscape. For investors eyeing opportunities in smaller or newer companies, penny stocks—though an outdated term—still hold potential for growth at accessible price points. These stocks can offer notable value when backed by strong financials, making them intriguing options for those seeking hidden gems with promising long-term prospects. Name Share Price Market Cap Financial Health Rating Halcyon Technology (SET:HTECH) THB2.64 THB792M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.176 SGD35.06M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.90 HK$3.28B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.26B ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.04 HK$1.7B ★★★★★★ Click here to see the full list of 1,161 stocks from our Asian Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: HighTide Therapeutics, Inc. is a biopharmaceutical company focused on discovering, researching, developing, and commercializing therapies for metabolic and digestive diseases in Mainland China, with a market cap of HK$1.42 billion. Operations: HighTide Therapeutics, Inc. has not reported any specific revenue segments at this time. Market Cap: HK$1.42B HighTide Therapeutics, Inc., a pre-revenue biopharmaceutical company, recently announced positive Phase 3 trial results for its lead compound HTD1801 in treating type 2 diabetes mellitus. Despite its lack of revenue and current unprofitability, the company has a strong financial position with short-term assets exceeding liabilities and more cash than debt. The management team is experienced, although the board is relatively new. HighTide's stock remains highly volatile, reflecting typical penny stock characteristics. The upcoming NDA submission for HTD1801 could be pivotal if approved by China's regulatory authorities later this year. Take a closer look at HighTide Therapeutics' potential here in our financial health report. Gain insights into HighTide Therapeutics' past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Shandong Molong Petroleum Machinery Company Limited, along with its subsidiaries, focuses on the design, research and development, production, and sale of energy equipment products and services both in China and internationally, with a market cap of HK$3.06 billion. Operations: No specific revenue segments are reported for Shandong Molong Petroleum Machinery Company Limited. Market Cap: HK$3.06B Shandong Molong Petroleum Machinery has shown a mix of financial challenges and operational resilience. Despite being unprofitable, the company maintains a positive cash runway for over three years, supported by CN¥2 billion in short-term assets exceeding its liabilities. However, its high net debt to equity ratio of 201.3% and increased debt levels highlight financial strain. The recent earnings report shows improved revenue but a significant drop in net income compared to the previous year, indicating volatility typical of penny stocks. Management's lack of experience could impact strategic decisions as they navigate these complexities. Unlock comprehensive insights into our analysis of Shandong Molong Petroleum Machinery stock in this financial health report. Assess Shandong Molong Petroleum Machinery's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Chongqing Lummy Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and sale of pharmaceutical products in China with a market cap of CN¥3.92 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥812.87 million. Market Cap: CN¥3.92B Chongqing Lummy Pharmaceutical faces financial challenges typical of penny stocks, with a net loss of CN¥13.78 million reported for Q1 2025 despite revenue growth to CN¥198.4 million. The company is unprofitable but has improved its debt profile, reducing the debt-to-equity ratio from 74.9% to 18.6% over five years and maintaining more cash than total debt, providing a stable cash runway exceeding three years even if free cash flow declines. Short-term assets of CN¥1.5 billion comfortably cover liabilities, though ongoing losses necessitate careful management by its experienced leadership team averaging over eight years in tenure. Click to explore a detailed breakdown of our findings in Chongqing Lummy Pharmaceutical's financial health report. Review our historical performance report to gain insights into Chongqing Lummy Pharmaceutical's track record. Click this link to deep-dive into the 1,161 companies within our Asian Penny Stocks screener. Looking For Alternative Opportunities? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2511 SEHK:568 and SZSE:300006. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
